Elite Pharmaceuticals Launches Generic Vyvanse for ADHD Market
https://www.tipranks.com/news/company-announcements/elite-pharmaceuticals-launches-generic-vyvanse-for-adhd-market Elite Pharmaceuticals ( (ELTP) ) has issued an update. Elite Pharmaceuticals announced the launch of its generic version of Vyvanse® (Lisdexamfetamine Disylate) in various strengths, targeting the ADHD treatment market. The product, which is marketed under the Elite Laboratories, Inc. label, is expected to capture a portion of the $4.3 billion annual sales reported … Read more